Canaccord Hot And Cold On Deals By Teva Pharmaceutical, ImmunoGen By: Benzinga via Benzinga March 31, 2015 at 15:52 PM EDT A spate of biotech deals took place this week as Teva Pharmaceutical Industries Ltd.(NYSE: TEVA) agreed to acquire Auspex ... Read More >> Related Stocks: Immunogen Inc Nasdaq Biotechnology Ishares ETF Roche Holding AG Basel American Depositary Shares Teva Pharmaceutical Industries ADR